You searched for "innovation"

2436 results found

Profile of presentation, follow-up and management of orbital myositis

This retrospective study reviewed the demographic characteristics of patients with orbital myositis, their clinical profile, management options, outcomes and predictive factors for recurrence. The study included 52 patients (55 eyes; 3% bilateral involvement), 36 females, with mean age at presentation...

RCOphth Annual Congress - Day 1

Follow all the updates from the first day of the RCOphth 2022 Annual Congress here.

Inequities in access to education for blind and partially sighted children

Leading Scottish vision impairment organisations call on Scottish Government to endorse new framework for vision impairment education.

SpaMedica extends its ophthalmic training programme, creating vital placements for NHS registrars

The UK’s largest provider of NHS cataract surgery is already supporting 60 aspiring surgeons, and has recently appointed three staff members to further develop its training provision.

Ellen aims to inspire a future focused on accessibility

Ellen Doherty, 47, who has macular degeneration due to Stargardt’s disease, became one of Scotland’s first Sight Loss Council volunteers earlier this year and is determined to inspire others to make accessibility a priority. Ellen and Callum Lancashire, Engagement Manager,...

Sight Scotland partners with Pleasance to boost accessibility for thousands at Edinburgh Fringe

Sight Scotland, supported by Sight Loss Councils, has partnered with famous fringe venue the Pleasance to deliver specialist visual impairment awareness training to over 250 of its staff ahead of this year’s Edinburgh Festival Fringe. The training is set to...

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

The focus group

I love conferences. Euretina I love above all others, and when it came to London in 2014 I was determined to attend. A few weeks before the conference was scheduled to begin a well-known pharmaceutical company sent me an email...

Dec/Jan 2019 Quiz

History A 72-year-old male presented to his GP with a large ulcerated lesion on his right lower eyelid present for six months and enlarging in size. He had an urgent referral to a tertiary centre for specialised examination. The lesion...

The results of the last survey Feb21

Once again, I am grateful for the responses and read the results with interest. I am always surprised by the amount of practice variation I see. I fully accept there is art in what we do and there is no...

The results of the last survey Apr21

There was a really fascinating response to the last edition’s practice variance survey. Strictly speaking, I cheated and this was not really about practice variation, but more about your impressions about what represents negligent practice. For the first time ever,...